Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Isofol Medical AB ( (SE:ISOFOL) ) is now available.
Isofol Medical AB has announced a rights issue to raise approximately SEK 86.1 million, fully guaranteed through subscription commitments and guarantee undertakings. This financial move, approved by an extraordinary general meeting, underscores strategic support from key stakeholders, including existing shareholders and partners, to bolster the company’s financial position and support its ongoing operations.
More about Isofol Medical AB
Isofol Medical AB is a biotechnology company based in Gothenburg, Sweden, focusing on developing novel cancer therapies. The company is listed on Nasdaq Stockholm and aims to enhance the efficacy of existing cancer treatments through its innovative products.
Average Trading Volume: 728,025
Current Market Cap: SEK277.3M
For an in-depth examination of ISOFOL stock, go to TipRanks’ Overview page.